Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.56
- Piotroski Score 3.00
- Grade Outperform
- Symbol (MGTX)
- Company MeiraGTx Holdings plc
- Price $5.97
- Changes Percentage (0.22%)
- Change $0.01
- Day Low $5.81
- Day High $5.97
- Year High $7.60
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $9.00
- High Stock Price Target $9.00
- Low Stock Price Target $9.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.19
- Trailing P/E Ratio -4.01
- Forward P/E Ratio -4.01
- P/E Growth -4.01
- Net Income $-84,027,000
Income Statement
Quarterly
Annual
Latest News of MGTX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts?
The article discusses the best-rated penny stocks, focusing on MeiraGTx Holdings plc (NASDAQ: MGTX) and its potential in gene therapy. The company's strategic partnerships and innovative pipeline posi...
By Yahoo! Finance | 2 months ago -
MeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 28% stake, while 21% is held by individual investors
MeiraGTx Holdings plc's shareholder analysis reveals private equity firms as the largest group with 28% ownership, followed by individual investors at 21%....
By Yahoo! Finance | 3 months ago -
MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 86% if they invested five years ago
Long-term investing is recommended, but not all stocks should be held indefinitely to avoid significant losses. MeiraGTx Holdings (NASDAQ: MGTX) experienced a sharp decline in share price over the yea...
By Yahoo! Finance | 4 months ago
